Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1563447125;47126;47127 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
N2AB1399342202;42203;42204 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
N2A1306639421;39422;39423 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
N2B656919930;19931;19932 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
Novex-1669420305;20306;20307 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
Novex-2676120506;20507;20508 chr2:178618650;178618649;178618648chr2:179483377;179483376;179483375
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGG
  • RefSeq wild type template codon: TCC
  • Domain: Ig-108
  • Domain position: 67
  • Structural Position: 153
  • Q(SASA): 0.686
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/K None None 0.78 N 0.606 0.107 0.329540904979 gnomAD-4.0.0 1.5944E-06 None None None None N None 0 0 None 4.77692E-05 0 None 0 0 0 0 0
R/S None None 0.103 N 0.343 0.145 0.0611884634855 gnomAD-4.0.0 6.84754E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99986E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.4711 ambiguous 0.5295 ambiguous -0.861 Destabilizing 0.702 D 0.621 neutral None None None None N
R/C 0.2022 likely_benign 0.2573 benign -0.848 Destabilizing 0.999 D 0.683 prob.neutral None None None None N
R/D 0.681 likely_pathogenic 0.7292 pathogenic -0.01 Destabilizing 0.976 D 0.641 neutral None None None None N
R/E 0.413 ambiguous 0.4652 ambiguous 0.128 Stabilizing 0.919 D 0.617 neutral None None None None N
R/F 0.599 likely_pathogenic 0.6536 pathogenic -0.679 Destabilizing 0.988 D 0.691 prob.neutral None None None None N
R/G 0.4066 ambiguous 0.4693 ambiguous -1.17 Destabilizing 0.811 D 0.627 neutral N 0.512227325 None None N
R/H 0.1199 likely_benign 0.1433 benign -1.505 Destabilizing 0.076 N 0.283 neutral None None None None N
R/I 0.2528 likely_benign 0.279 benign -0.029 Destabilizing 0.988 D 0.692 prob.neutral None None None None N
R/K 0.1209 likely_benign 0.1356 benign -0.754 Destabilizing 0.78 D 0.606 neutral N 0.502407712 None None N
R/L 0.2767 likely_benign 0.3228 benign -0.029 Destabilizing 0.919 D 0.635 neutral None None None None N
R/M 0.3168 likely_benign 0.3604 ambiguous -0.443 Destabilizing 0.999 D 0.673 neutral N 0.51283326 None None N
R/N 0.5065 ambiguous 0.5548 ambiguous -0.35 Destabilizing 0.919 D 0.625 neutral None None None None N
R/P 0.6624 likely_pathogenic 0.707 pathogenic -0.286 Destabilizing 0.988 D 0.702 prob.neutral None None None None N
R/Q 0.1165 likely_benign 0.1334 benign -0.46 Destabilizing 0.988 D 0.649 neutral None None None None N
R/S 0.5306 ambiguous 0.587 pathogenic -1.123 Destabilizing 0.103 N 0.343 neutral N 0.507081171 None None N
R/T 0.2501 likely_benign 0.2696 benign -0.793 Destabilizing 0.811 D 0.653 neutral N 0.508140706 None None N
R/V 0.3538 ambiguous 0.4024 ambiguous -0.286 Destabilizing 0.976 D 0.666 neutral None None None None N
R/W 0.2373 likely_benign 0.2784 benign -0.352 Destabilizing 0.999 D 0.687 prob.neutral N 0.513657448 None None N
R/Y 0.4069 ambiguous 0.4883 ambiguous -0.071 Destabilizing 0.976 D 0.705 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.